Cargando…
AB007. Neurotensin derived from cancer stroma contributes to castration resistance via promoting neuroendocrine transdifferentiation
The mechanism of neuroendocrine transdifferentiation (NED) during the development of castration-resistant prostate cancer (CRPC) remains undefined. Although androgen-deprivation therapy (ADT) can impair tumor cell growth, ADT can also triggers a parallel reaction, leading to increased neurotensin (N...
Autores principales: | Zhu, Shimiao, Shang, Zhiqun, Tian, Hao, Flores-Morales, Amilcar, Niu, Yuanjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842563/ http://dx.doi.org/10.21037/tau.2016.s007 |
Ejemplares similares
-
Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer
por: Zhu, Shimiao, et al.
Publicado: (2019) -
Correction: Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer
por: Zhu, Shimiao, et al.
Publicado: (2019) -
AB007. Testosterone and radiotherapy for prostate cancer
por: Incrocci, Luca
Publicado: (2015) -
AB17. ADT treatment promotes PCa EMT and metastasis
por: Niu, Yuan-Jie
Publicado: (2014) -
AB07. Ureteroscopy: tips and tricks
por: Chi, Thomas
Publicado: (2014)